Michael Tanen

4.3k citations
21 papers · 2.2k · h-index 14

Impact in

Papers in

  • Molecular Biology 9
    • Peroxisome Proliferator-Activated Receptors 4
    • Retinoids in leukemia and cellular processes 3
  • Physiology 9
    • Alzheimer's disease research and treatments 5
    • Adipose Tissue and Metabolism 3
Co-authors
Joel P. Berger (4 shared papers)David E. Moller (4 shared papers)Karen Snyder (5 shared papers)Gary Herman (3 shared papers)Wesley Tanaka (3 shared papers)Arthur Bergman (3 shared papers)Bingming Yi (2 shared papers)John A. Wagner (5 shared papers)
Journals
Alzheimer s & Dementia (4 papers)Clinical Pharmacology & Therapeutics (2 papers)Molecular Endocrinology (2 papers)Journal of Biological Chemistry (2 papers)Endocrinology (1 paper)
Partner nations
United StatesUnited KingdomNetherlands

In The Last Decade

Michael Tanen

21 papers receiving 2.1k citations

Peers

Michael Tanen
Comparison fields: 5 of 100
  • Endocrinology, Diabetes and Metabolism 886
  • Physiology 659
  • Endocrine and Autonomic Systems 128
  • Pharmacology 307
  • Molecular Biology 972
Replace Anca D. Dobrian with:
Anca D. Dobrian United States
Hiroyuki Odaka Japan
Nadeeja Wijesekara Canada
Nobuo Sakamoto Japan
James R. Paterniti United States
Asger Lund Denmark
Michael Mark Germany
Randy L. Webb United States
Philip D.G. Miles United States
J Saye United States
Michael Tanen relative to Anca D. Dobrian United States Anca D. Dobrian's profile →
Citations per field
00.5×1.6×
Anca D. Dobrian · 1×
Citations per year

Countries citing papers authored by Michael Tanen

Since Specialization
Citations

This map shows the geographic impact of Michael Tanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Tanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Tanen more than expected).

Fields of papers citing papers by Michael Tanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Tanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Tanen. The network helps show where Michael Tanen may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Tanen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Tanen Line = papers co-authored together Michael Tanen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPARγ Agonists: A Potential Mechanism of Insulin Sensitization
Endocrinology ·Terry P. Combs, John A. Wagner, Joel P. Berger, Tom Doebber, Wenjun Wang, Bei B. Zhang, Michael Tanen, Anders H. Berg, Stephen O’Rahilly, David B. Savage, Krishna Chatterjee, Stuart Weiss, Patrick Larson, Keith Gottesdiener, Barry J. Gertz, Maureen Charron, Philipp E. Scherer, David E. Moller
2002497
2
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses
Clinical Pharmacology & Therapeutics ·Gary Herman, C. Melinda Stevens, Koen Vandyck, Arthur Bergman, Bingming Yi, M DESMET, Karen Snyder, D Hilliard, Michael Tanen, Wesley Tanaka
2005414
3
Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein γ Selective Modulator
Molecular Endocrinology ·Joel P. Berger, Ann Petro, Karen L. MacNaul, Linda J Kelly, Bei B. Zhang, Karen Richards, Alex Elbrecht, Bruce A. Johnson, Gaochao Zhou, Thomas W. Doebber, Chhabi Biswas, Mona Parikh, Neelam Sharma, Michael Tanen, G M Thompson, John Ventre, Alan D. Adams, Ralph Mosley, Richard S. Surwit, David E. Moller
2003271
4
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers
Clinical Therapeutics ·Arthur Bergman, Catherine Stevens, Yanyan Zhou, Bingming Yi, Martine E. Laethem, Marina De Smet, Karen Snyder, Deborah Hilliard, Wesley Tanaka, Wei Zeng, Michael Tanen, Amy Q. Wang, Li Chen, Gregory A. Winchell, Michael J. Davies, Steven Ramael, John A. Wagner, Gary Herman
2006220
5
Peroxisome Proliferator-activated Receptor-γ Ligands Inhibit Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity
Journal of Biological Chemistry ·Joel P. Berger, Michael Tanen, Alex Elbrecht, Anne Hermanowski‐Vosatka, David E. Moller, Samuel D. Wright, Rolf Thieringer
2001175
6
Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP‐4 Inhibitor Sitagliptin in Middle‐Aged Obese Subjects
The Journal of Clinical Pharmacology ·Gary Herman, Arthur Bergman, Fang Liu, Cathy Stevens, Amy Q. Wang, Wei Zeng, Li Chen, Karen Snyder, Deborah Hilliard, Michael Tanen, Wesley Tanaka, Alan G. Meehan, Kenneth C. Lasseter, Stacy C. Dilzer, Robert A. Blum, John A. Wagner
2006146
7
Localization of PPARδ in murine central nervous system: expression in oligodendrocytes and neurons
Brain Research ·John Woods, Michael Tanen, David J. Figueroa, Chhabi Biswas, Emanuel Zycband, David E. Moller, Christopher P. Austin, Joel P. Berger
200396
8
Cerebrospinal Fluid Biomarkers Distinguish Postmortem-Confirmed Alzheimer's Disease from Other Dementias and Healthy Controls in the OPTIMA Cohort
Journal of Alzheimer s Disease ·Jeffrey L. Seeburger, Daniel Holder, Marc Combrinck, Catharine Joachim, Omar Laterza, Michael Tanen, Aimée Dallob, Derek L Chappell, Karen Snyder, Mary Flynn, Adam Simon, Vijay Modur, William Z. Potter, Gordon Wilcock, Mary J. Savage, A. David Smith
201562
9
Quantification of Tau in Cerebrospinal Fluid by Immunoaffinity Enrichment and Tandem Mass Spectrometry
Clinical Chemistry ·Thomas McAvoy, Michael E. Lassman, Daniel S. Spellman, Zhenlian Ke, Bonnie J. Howell, Oitak Wong, Zhu Lan, Michael Tanen, Arie Struyk, Omar Laterza
201459
10
Ligand Modulates the Interaction of Thyroid Hormone Receptor β with the Basal Transcription Machinery
Journal of Biological Chemistry ·Guo‐Xia Tong, Michael Tanen, Milan K. Bagchi
199540
11
Transcriptional Silencing by Unliganded Thyroid Hormone Receptor β Requires a Soluble Corepressor That Interacts with the Ligand-Binding Domain of the Receptor
Molecular and Cellular Biology ·Guo-Xia Tong, M. Jeyakumar, Michael Tanen, Milan K. Bagchi
199639
12
P4‐196: The novel BACE inhibitor MK‐8931 dramatically lowers cerebrospinal fluid Aβ peptides in healthy subjects following single‐ and multiple‐dose administration
Alzheimer s & Dementia ·Mark S. Forman, John Palcza, Jack Tseng, J. Leempoels, Steven Ramael, David Han, Stanford S. Jhee, Larry Ereshefsky, Michael Tanen, Omar Laterza, Marissa F. Dockendorf, Gopal Krishna, Lei Ma, John A. Wagner, Matthew D. Troyer
201238
13
Analysis of the Functional Role of Steroid Receptor Coactivator-1 in Ligand-Induced Transactivation by Thyroid Hormone Receptor
Molecular Endocrinology ·M. Jeyakumar, Michael Tanen, Milan K. Bagchi
199738
14
Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK‐8931) in Healthy Japanese Adults: A Randomized, Placebo‐Controlled Study
Clinical Pharmacology & Therapeutics ·K. Chris Min, Marissa F. Dockendorf, John Palcza, Jack Tseng, Lei Ma, Julie A. Stone, Huub Jan Kleijn, Peter Hodsman, Kazuko Masuo, Michael Tanen, Matthew D. Troyer, Marianne van Vugt, Mark S. Forman
201818
15
Evaluation of Urinary Renal Biomarkers for Early Prediction of Acute Kidney Injury Following Partial Nephrectomy: A Feasibility Study
European Urology Focus ·Brian R. Lane, Stephen K. Babitz, Kateřina Vlasáková, Allen Wong, Sabrina L. Noyes, William Boshoven, Pam Grady, Cindy Zimmerman, Susan Engerman, Maureen Gebben, Michael Tanen, Warren E. Glaab, Frank D. Sistare
201813
16
Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergen
European Clinical Respiratory Journal ·Rob Zuiker, Marcella Ruddy, Nicoletta Morelli, Robin Mogg, Veronica M. Rivas, Kristien Van Dyck, Inge De Lepeleire, Michael Tanen, J. D. Boot, Ingrid M. C. Kamerling, Zuzana Diamant
201510
17
O4–05–05: Consistency of BACE inhibitor‐mediated brain amyloid production inhibition by MK‐8931 in Alzheimer's disease patients and healthy young adults
Alzheimer s & Dementia ·Julie A. Stone, Huub Jan Kleijn, Marissa F. Dockendorf, Lei Ma, John Palcza, Jack Tseng, Michael Tanen, Mark S. Forman
20136
18
Next Generation Ligand Binding Assays—Review of Emerging Real-Time Measurement Technologies
The AAPS Journal ·Stephanie Fraser, Mark J. Cameron, Edward O’Connor, Martin Schwickart, Michael Tanen, Mark Ware
20144
19
P1‐225: A study to evaluate the pharmacokinetics and pharmacodynamics of single and multiple oral doses of the novel BACE inhibitor MK‐8931 in Japanese subjects
Alzheimer s & Dementia ·K. Chris Min, Mark S. Forman, Marissa F. Dockendorf, John Palcza, Peter Soni, Lei Ma, Gopal Krishna, Peter Hodsman, Kazuko Masuo, Michael Tanen, John A. Wagner, Matthew D. Troyer
20123
20
Detection Of Increased Levels Of Th2-derived Cytokines In Ultracentrifuged Sputum Following Allergen Challenge And Their Responsiveness To Fluticasone
Marcella Ruddy, Rob Zuiker, Nicoletta Morelli, Robin Mogg, Verónica Rivas, Kristien Van Dyck, Inge De Lepeleire, Michael Tanen, A Pica-Mendez, Zuzana Diamant
20102

About Michael Tanen

Michael Tanen is a scholar working on Molecular Biology, Physiology, Endocrinology, Diabetes and Metabolism, Immunology and Pharmacology, having authored 21 papers that have together received 2.2k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Computational Drug Discovery Methods (3 papers), Peptidase Inhibition and Analysis (3 papers), Retinoids in leukemia and cellular processes (3 papers), Adipose Tissue and Metabolism (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Diabetes Treatment and Management (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (886 citations), Physiology (659 citations), Endocrine and Autonomic Systems (128 citations), Pharmacology (307 citations) and Molecular Biology (972 citations). Michael Tanen has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Joel P. Berger, David E. Moller, Karen Snyder, Gary Herman, Wesley Tanaka, Arthur Bergman, Bingming Yi, John A. Wagner, Koen Vandyck and C. Melinda Stevens. Their work appears in journals such as Alzheimer s & Dementia, Clinical Pharmacology & Therapeutics, Molecular Endocrinology, Journal of Biological Chemistry and Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anca D. DobrianBreakdown of academic impact, for papers by Hiroyuki OdakaBreakdown of academic impact, for papers by Nadeeja WijesekaraBreakdown of academic impact, for papers by Nobuo SakamotoBreakdown of academic impact, for papers by James R. PaternitiBreakdown of academic impact, for papers by Asger LundBreakdown of academic impact, for papers by Michael MarkBreakdown of academic impact, for papers by Randy L. WebbBreakdown of academic impact, for papers by Philip D.G. MilesBreakdown of academic impact, for papers by J Saye